Skip to content

Drug interactions

Dalteparin + Reteplase

Severity: Major

Dalteparin and Reteplase: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Reteplase is a thrombolytic, and giving it with or after an anticoagulant such as dalteparin markedly increases the risk of serious bleeding, including intracranial hemorrhage. The combination is used only in defined settings such as acute myocardial infarction under specialist protocols.

What this interaction means in plain words

Dalteparin and Reteplase can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: High

Why it happens

Plasminogen activation causes fibrinolysis while dalteparin inhibits clot formation via factor Xa, producing additive hemorrhagic risk.

What to do

Use only under a specialist protocol with defined timing of anticoagulant administration. Monitor closely for bleeding and neurological changes, and avoid invasive procedures.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dalteparin and Reteplase, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dalteparin with Reteplase?

MediHelp rates the interaction as major. Dalteparin and Reteplase can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Reteplase is a thrombolytic, and giving it with or after an anticoagulant such as dalteparin markedly increases the risk of serious bleeding, including intracranial hemorrhage. The combination is used only in defined settings such as acute myocardial infarction under specialist protocols.

How serious is the interaction between Dalteparin and Reteplase?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use only under a specialist protocol with defined timing of anticoagulant administration. Monitor closely for bleeding and neurological changes, and avoid invasive procedures.

What other medicines interact with Dalteparin?

MediHelp also lists interactions of Dalteparin with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dalteparin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in